Camcevi
Product Images NDC 72851-042

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Camcevi (NDC 72851-042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Foresee Pharmaceuticals Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure0007)

A line graph depicting serum testosterone percent change over time in days, from 0 to 336. The y-axis shows percent change ranging from -100% to over 50%. Data points indicate a rapid decline in serum testosterone shortly after the start, approaching -100% change and maintaining close to that level over the extended period. The sample size (N) at various time points is listed below the x-axis.*

FDA Label Image

Figure (Figure0008)

An instructional illustration showing two parts labeled A and B, resembling a syringe-like device and an oral assembly component. A small image of a Point-Lok® device is shown to the right, indicating the connection or locking mechanism. The diagram is related to the use or assembly of CAMCEVI's delivery system.*

FDA Label Image

Figure (Figure0009)

An instructional illustration showing two components labeled A and B for the CAMCEVI product. Component A appears to be a syringe-like applicator with a plunger, and component B is a smaller, capped tube or cartridge, both likely parts of the CAMCEVI delivery system from Foresee Pharmaceuticals Co., Ltd.*

FDA Label Image

Figure (Figure001)

An instructional illustration showing two components labeled A and B. Component A appears to be a syringe-like device with a plunger and a nozzle, while component B is a smaller capped vial or cartridge. The image suggests assembly or usage steps for the components.*

FDA Label Image

Figure (Figure0010)

An instructional diagram showing two hands assembling a device by aligning and connecting two parts labeled A and B. The left hand holds part B and the right hand holds part A, with orange arrows indicating the twisting and pushing motions required to join the parts.*

FDA Label Image

Figure (Figure0011)

An illustration diagram showing the components of a prefilled syringe used for CAMCEVI. Labeled parts include Needle and Cover, Product, End Stopper, Barrel, Backstop, Plunger, Rod, and a separate Point-Lok component.*

FDA Label Image

Figure (Figure0012)

An instructional illustration showing a hand grasping a cloth or fabric, likely depicting a step in a usage or handling procedure.*

FDA Label Image

Figure (Figure0013)

An instructional illustration showing a hand holding a syringe at a 90-degree angle injecting into the skin of the abdomen. The image highlights proper injection technique with the angle marked clearly.*

FDA Label Image

Figure (Figure0014)

An instructional diagram showing two steps of preparing a syringe with a vial. Step 1 depicts inserting a needle into the vial with a downward arrow, and Step 2 shows another syringe action with a downward arrow, indicating sequential steps for drawing medication.*

FDA Label Image

Figure (Figure002)

An instructional illustration showing hands connecting two parts of a device by aligning and rotating them. Arrows labeled A and B indicate the direction to attach or loosen the components, demonstrating proper assembly.*

FDA Label Image

Figure (Figure003)

An instructional diagram showing the components of a CAMCEVI prefilled delivery device. Labeled parts include Needle and Cover, Product, End Stopper, Barrel, Backstop, Plunger, Rod, and an additional separate part labeled Point-Lok®.*

FDA Label Image

Figure (Figure004)

An illustration showing a hand pinching or grasping the skin on an arm or shoulder area, possibly indicating preparation for a subcutaneous injection or skin test application.*

FDA Label Image

Figure (Figure005)

An instructional illustration showing a hand holding a syringe at a 90-degree angle, preparing to inject into a surface. The image emphasizes the correct injection angle for administration.*

FDA Label Image

Figure (Figure006)

An instructional illustration showing two steps for using a syringe with a vial or container. Step 1 shows inserting the needle into the vial with a downward arrow, and Step 2 shows pushing down on the syringe plunger with a downward arrow, indicating fluid extraction or injection.*

FDA Label Image

Front (Image00001)

CAMCEVI 42 mg single-dose prefilled syringe injectable emulsion packaging label. The box displays the product name, active ingredient (leuprolide), and strength. It is a single-dose administration kit for subcutaneous injection once every 6 months. The label notes the inclusion of a sterile prefilled syringe, needle, needle protection device, and prescribing information. The labeler is Foresee Pharmaceuticals Co., Ltd.*

FDA Label Image

Back (Image00002)

CAMCEVI syringe assembly and administration instructions are printed on an orange and white carton from Foresee Pharmaceuticals Co., Ltd. The panel illustrates step-by-step syringe assembly, preparing the injection site, administering treatment, and needle protection, with labeled diagrams and textual guidance for proper use.*

FDA Label Image

Image Description (Image0001)

CAMCEVI 42 mg injectable emulsion in a single-dose prefilled syringe. The label shows the proprietary name CAMCEVI with the active ingredient leuprolide specified, presented by Foresee Pharmaceuticals Co., Ltd.*

FDA Label Image

Image Description (Image0003)

CAMCEVI (leuprolide) injectable emulsion label displays the product name and active ingredient. It is a 42 mg single-dose prefilled syringe intended for subcutaneous injection only. The label includes the NDC number 72851-042-01 and indicates prescription use only. Foresee Pharmaceuticals Co., Ltd., based in Taipei City, Taiwan, is the labeler.*

FDA Label Image

Image Description (Image0004)

CAMCEVI (leuprolide) injectable emulsion 42 mg single-dose prefilled syringe packaging label. The blister carton contains one sterile 42 mg prefilled syringe and one sterile 18-gauge needle. The label includes storage instructions, administration guidelines, manufacturer information (Foresee Pharmaceuticals Co., Ltd., Taiwan; product from France), and barcode with lot and expiration details.*

FDA Label Image

Structure (Structure0001)

Chemical structure of the active ingredient in CAMCEVI, showing a complex cyclic peptide with multiple amino acid residues, hydroxyl groups, and an attached sulfonic acid hydrate moiety (CH3SO3H, n=1.5-1.8). The structure is detailed with stereochemistry indicated by wedge bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.